Frontotemporal dementia is a serious brain disorder that affects how people think, behave, and communicate. Although it is not as widely known as Alzheimer’s disease, it is actually one of the leading causes of dementia in younger adults.
Many patients begin to show symptoms in their forties or fifties, and sometimes even earlier. Because it affects areas of the brain responsible for personality, judgment, and language, the first signs of the disease can look very different from the memory loss usually associated with dementia.
People with frontotemporal dementia may start acting in unusual ways. They might lose empathy, make impulsive decisions, or behave in ways that seem socially inappropriate. Others may develop language problems, such as difficulty finding words or understanding conversations.
These symptoms can be confusing for families and doctors because they often resemble stress, depression, or personality changes rather than a neurological illness. As a result, it can take years before patients receive an accurate diagnosis.
Scientists have been trying for decades to understand what causes different forms of frontotemporal dementia. Some cases run in families and are clearly linked to inherited genetic mutations. However, many patients appear to develop the disease without any family history, which makes the condition much harder to study.
A new study has now uncovered an important genetic clue behind one rare form of frontotemporal dementia. The research was conducted by scientists at VIB and the University of Antwerp in Belgium. Their findings were published in the scientific journal Nature Genetics.
The discovery focuses on a rare subtype of the disease known as atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions, often abbreviated as aFTLD-U.
This form of dementia has been especially difficult for scientists to study because it is uncommon and usually appears in patients without a known inherited risk. In addition, a definite diagnosis is often only confirmed after death through detailed examination of brain tissue.
Professor Rosa Rademakers, who leads research at the VIB-UAntwerp Center for Molecular Neurology, has spent many years studying the genetics of frontotemporal dementia. She explains that this disease often strikes people while they are still working and raising families.
Because early symptoms can look like changes in personality or behavior, patients may struggle with work, relationships, and daily life before anyone realizes a neurological illness is responsible.
The research team set out to search for hidden genetic risk factors that might explain why some people develop this rare form of dementia. Gathering enough patient samples for such a study was extremely challenging. The scientists needed confirmed cases of the disease and had to work with international collaborators to collect genetic data from patients around the world.
Eventually, the team analyzed genetic information from 59 patients who had been definitively diagnosed with aFTLD-U. They compared these genetic profiles with data from thousands of people without the disease.
This type of investigation is known as a genome-wide association study, which allows researchers to search the entire human genome for genetic differences linked to a disease.
The scientists discovered an unusual genetic change in a gene called GOLGA8A. Specifically, they found what is known as a repeat expansion. This occurs when a short sequence of DNA letters repeats itself many times in a row. While small repeats are common in the human genome, longer expansions can sometimes disrupt normal gene activity and lead to disease.
In this study, the researchers found that longer repeat expansions in the GOLGA8A gene were strongly linked to the rare dementia subtype. Remarkably, the repeat consisted of only two DNA building blocks repeated many times. A
lthough repeat expansions have been associated with several neurological disorders, this is the first time scientists have discovered a disease-related repeat made up of just two nucleotides.
The discovery was made possible by a relatively new technology called long-read DNA sequencing. Traditional sequencing methods read DNA in very small pieces, which makes it difficult to study complicated regions of the genome.
Long-read sequencing allows scientists to read much longer stretches of DNA at once, making it easier to detect unusual genetic structures such as repeat expansions.
Dr. Wouter De Coster, a researcher involved in the study, explained that the genetic signal discovered in the analysis was unusually strong.
Even in much larger studies of common diseases, researchers rarely observe associations this powerful. In this case, the repeat expansion appeared in nearly 60 percent of patients with the rare dementia subtype, suggesting it plays a major role in the disease.
Although the finding answers some questions, many mysteries remain. Scientists still do not fully understand how this genetic repeat leads to damage in the brain. The research team is now investigating how the repeat expansion might affect gene activity, cellular processes, and the health of neurons in brain regions involved in behavior and language.
Another important question is why some people who carry the genetic repeat develop the disease while others do not. This suggests that other genetic factors or environmental influences may also contribute to the condition.
Despite these unanswered questions, the discovery represents a major step forward. Identifying a clear genetic risk factor provides scientists with a starting point for understanding the biological processes behind the disease. It may also help doctors develop better diagnostic tests and identify patients earlier.
In the future, this type of genetic knowledge could guide the development of targeted treatments designed to address the underlying cause of the disease rather than just treating symptoms. Researchers hope that studying this newly identified genetic mechanism will eventually lead to therapies that slow or prevent brain damage.
The study also carries a broader message about diseases that appear to occur randomly. Even when a condition does not run in families, there may still be hidden genetic factors involved. Discovering these factors can improve diagnosis and open new paths for treatment.
When analyzing the findings, the research appears particularly significant because it provides the first strong biological clue for a disease subtype that was previously poorly understood. The study used advanced sequencing technology and carefully selected patient samples, which strengthens confidence in the results.
However, the number of patients studied was relatively small because the disease is so rare. Larger studies will be needed to confirm the findings and explore how the genetic repeat interacts with other risk factors.
Overall, the discovery offers new hope for patients and families affected by frontotemporal dementia. By uncovering a major genetic risk factor, scientists now have a clearer path toward understanding this devastating disease and eventually developing more effective treatments.
If you care about dementia, please read studies about dietary strategies to ward off dementia, and how omega-3 fatty acids fuel your mind.
For more health information, please see recent studies about Choline deficiency linked to Alzheimer’s disease, and what to eat (and avoid) for dementia prevention.
Copyright © 2026 Knowridge Science Report. All rights reserved.
